scPharmaceuticals/$SCPH
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About scPharmaceuticals
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.
Ticker
$SCPH
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
163
ISIN
US8106481059
Website
SCPH Metrics
BasicAdvanced
$213M
-
-$1.88
0.16
-
Price and volume
Market cap
$213M
Beta
0.16
52-week high
$5.43
52-week low
$1.94
Average daily volume
305K
Financial strength
Current ratio
5.478
Quick ratio
4.399
Long term debt to equity
-1,016.247
Total debt to equity
-1,021.201
Interest coverage (TTM)
-9.73%
Profitability
EBITDA (TTM)
-66.659
Gross margin (TTM)
68.92%
Net profit margin (TTM)
-216.24%
Operating margin (TTM)
-158.82%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
-49.20%
Return on equity (TTM)
-934.02%
Valuation
Price to revenue (TTM)
4.638
Price to book
-39.62
Price to tangible book (TTM)
-39.62
Price to free cash flow (TTM)
-2.782
Free cash flow yield (TTM)
-35.95%
Free cash flow per share (TTM)
-145.22%
Growth
Revenue change (TTM)
138.10%
Earnings per share change (TTM)
26.64%
3-year earnings per share growth (CAGR)
21.59%
What the Analysts think about SCPH
Analyst ratings (Buy, Hold, Sell) for scPharmaceuticals stock.
SCPH Financial Performance
Revenues and expenses
SCPH Earnings Performance
Company profitability
SCPH News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for scPharmaceuticals stock?
scPharmaceuticals (SCPH) has a market cap of $213M as of July 04, 2025.
What is the P/E ratio for scPharmaceuticals stock?
The price to earnings (P/E) ratio for scPharmaceuticals (SCPH) stock is 0 as of July 04, 2025.
Does scPharmaceuticals stock pay dividends?
No, scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next scPharmaceuticals dividend payment date?
scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders.
What is the beta indicator for scPharmaceuticals?
scPharmaceuticals (SCPH) has a beta rating of 0.16. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.